Skip to main content
. 2021 Feb 4;44(3):340–348. doi: 10.1002/clc.23533

TABLE 1.

Trends in baseline characteristics for atrial fibrillation hospitalizations in the setting of coexisting diabetes mellitus

Baseline characteristics 2004–2006 (weighted n = 208 042) 2007–2008 (weighted n = 180 042) 2009–2010 (weighted n = 211 419) 2011–2012 (weighted n = 239 256) 2013–2014 (weighted n = 236 195) Overall (weighted n = 1 075 770) p‐Trend
Age, mean (SE) 70.5 (0.08) 70.3 (0.09) 70.5 (0.10) 70.5 (0.08) 70.3 (0.06) 70.3 (0.04) .99
Female (%) 53.0 52.1 51.9 51.6 50.5 51.8 <.001
Age group (%)
18–44 years 2.2 2.4 2.1 2.1 2.0 2.1 .01
45–64 years 27.7 27.9 28.0 27.7 28.0 27.9 .59
65–74 years 28.9 29.3 29.7 30.2 31.1 29.9 <.001
≥75 years 41.3 40.4 40.2 40.0 38.9 40.1 <.001
Race (%)
White 57.6 59.8 67.4 72.5 74.6 66.8 <.001
Black 6.8 7.1 8.1 9.2 9.4 8.2 <.001
Hispanic 5.4 5.4 6.1 6.6 6.9 6.2 <.001
Asian or Pacific Islander 1.2 1.5 1.5 1.6 1.7 1.5 .001
Native American 0.4 0.6 0.6 0.6 0.5 0.5 .25
Others 1.5 1.9 2.1 2.1 2.1 2.0 .002
SES (%)
Quartile 1 28.1 28.1 28.0 30.1 29.9 28.9 .003
Quartile 2 27.3 28.4 28.2 26.3 28.7 27.8 <.001
Quartile 3 23.8 24.0 24.6 24.5 23.3 24.0 .63
Quartile 4 20.8 19.5 19.2 19.1 18.1 19.3 .002
Primary payer (%)
Medicare 70.1 68.5 68.5 70.9 70.8 69.9 <.001
Medicaid 4.5 4.3 5.0 4.8 5.7 4.9 <.001
Private insurance 21.1 22.6 21.6 19.5 18.7 20.7 <.001
Self pay/uninsured 2.3 2.3 2.7 2.6 2.5 2.5 .20
AHRQ comorbidity measure
AIDS (%) 0.03 0.04 0.04 0.04 0.04 0.04 .91
Alcohol abuse (%) 2.0 2.4 2.6 3.1 3.3 2.7 <.001
Deficiency anemias (%) 10.9 13.7 15.4 17.3 17.5 15.1 <.001
Rheumatoid arthritis/Collagen vascular diseases (%) 1.9 2.2 2.4 2.6 2.9 2.4 <.001
Chronic blood loss anemia (%) 0.6 0.6 0.5 0.6 0.5 0.6 .10
Congestive heart failure (%) 0.5 0.4 0.6 0.4 0.4 0.5 .15
COPD (%) 21.8 22.8 24.2 25.8 26.8 24.4 <.001
Coagulopathy (%) 2.2 2.6 3.3 3.7 4.0 3.2 <.001
Depression (%) 6.0 7.5 8.5 9.6 10.2 8.5 <.001
Diabetes, uncomplicated (%) 87.5 83.5 83.1 81.7 80.8 83.2 <.001
Diabetes with chronic complications (%) 10.7 10.8 10.6 11.5 12.0 11.2 <.001
Drug abuse (%) 0.5 0.6 0.7 1.1 1.4 0.9 <.001
Hypertension (%) 69.8 73.4 76.7 79.4 80.7 76.3 <.001
Hypothyroidism (%) 12.7 14.6 15.7 16.9 17.3 15.6 <.001
Liver disease (%) 1.2 1.4 1.8 2.0 2.5 1.8 <.001
Fluid and electrolyte disorders (%) 15.7 17.8 20.0 22.2 24.7 20.3 <.001
Other neurological disorders (%) 4.0 5.1 5.7 6.1 6.2 5.4 <.001
Obesity (%) 13.5 18.5 21.3 25.0 28.1 21.6 <.001
Paralysis (%) 1.3 1.5 1.4 1.5 1.4 1.4 .12
Peripheral vascular disease (%) 7.0 7.7 8.4 9.2 9.4 8.4 <.001
Psychoses (%) 1.7 2.1 2.3 2.9 2.9 2.4 <.001
Pulmonary circulation disorders (%) 0.04 0.1 0.2 0.1 0.1 0.1 <.001
Renal failure (%) 10.4 15.4 18.2 21.2 22.7 17.9 <.001
Solid tumor without metastasis (%) 1.9 1.9 2.0 2.1 2.1 2.0 .07
Valvular disease (%) 0.2 0.2 0.2 0.2 0.2 0.2 .16
Weight loss (%) 1.0 1.3 1.7 2.3 2.3 1.8 <.001
CCI, mean (SE) 2.0 (0.01) 2.2 (0.01) 2.3 (0.01) 2.4 (0.01) 2.5 (0.01) 2.29 (0.004) <.001
Hospital location and teaching status
Rural 16.6 15.7 15.4 14.6 13.2 15.0 <.001
Urban non‐teaching 46.0 45.2 45.6 42.3 34.7 42.5 <.001
Urban teaching 37.5 39.1 39.0 43.1 52.0 42.5 <.001
Hospital Region
Northeast 20.8 19.1 20.5 19.6 19.0 19.8 .06
Midwest 25.4 26.1 25.7 24.5 24.9 25.3 .14
South 39.7 40.1 39.2 41.0 41.4 40.3 .04
West 14.1 14.8 14.6 14.9 14.7 14.6 .26

Abbreviations: AHRQ, Agency for Healthcare Research and Quality; CCI, chronic condition, indicator.